Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus corticosteroids in severe alcoholic hepatitis
2020-004549-35Phase 4Active
- Sponsor
- Hospital Universitario Araba
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetylcysteine in alcoholic hepatitis (AH) (2 arms), sponsored by Hospital Universitario Araba. Primary endpoint: All-cause mortality at 6 months. Started Nov 2020; status: active.
02
Drugs
acetylcysteine
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2020-004549-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004549-35.